| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Thought Leadership in Action Series: Asking the Right Questions |
|
Digg It - Thought Leadership in Action Series: Asking the Right Questions
True thought leadership requires original thinking. It is a
practice that can be learned, or rather rediscovered, reclaimed,
with a certain amount of attention and surrender. As with any creative endeavor, originality in thinking, in being, requires a heightened state of alertness According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product , a bridging of
the poles, a show of fearlessness and willingness to forfeit the
known for the unknown, the learned for the experienced. It requires a trust deeper than the sea, for what it asks for is a letting go, an unmooring from the safe harbor of certainty for a journey into ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in the mists of mystery and possibility. When I was in elementary school, I learned to attach importance to things based on one’s willingness to die for them. The whole idea of heroes usually involved a sacrifice of someone’s life. Being willing to die for your country was the essence lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. of
patriotism. And as a young Catholic child, the chance to be a martyr for my faith was something I could only hope and pray for. We have learned to associate courage with risk, and with the question "what are you willing to die for?" But what if we ask "What are you willing to here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe live for?" If we determine for ourselves exactly what we choose to give our lives to, where we will direct our energy, what crises we’ll work to ameliorate or prevent, then we set ourselves on a trajectory that takes a mountainous courage to sustain. We need to refuel constantly t d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro o stay the course, to avoid obstacles, to
overcome resistance from ourselves and others. As thought leaders, it is our business to be asking questions—of ourselves as well as others—that help us all redefine what we are living for and why. The generation that is stepping up to lea ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ership is a generation
looking for curriculum and challenges that have an impact, that
engage the whole of their fertile imaginations in bridging the
gaps we have failed to bridge thus far in our shaping of a
culture. What we're in need of is thought leadership that leads people i easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi n
two directions: first, into their own deep recesses where they
can access their feelings, their desires, their most basic human
instincts, and identify what it is they are truly called to. This is a leadership of creativity and imagination that frees people from their social con nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically itioning, familial expectations,
religious and cultural programming long enough to enable their
unique originality to surface. It is a process of self-definition, a washing away of all that is not authentic, a clarifying of one’s essence. The questions are personal: What activitie and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ s bring you joy and
peace? To what do you aspire? What do you perceive as obstacles
to your success? What inspires you? If you could imagine yourself capable of fixing one broken thing, or creating one thing that doesn't yet exist, what would it be? When you were a child, what did ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi you want to be when you
grew up? What did you imagine that profession would give you?
What would have to happen for you to have that now? The next step is to move toward fulfillment. Any deep inquiry into the self will lead to a heightened sense of our interconnectedness and inter ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ependence on each other. Who we
are, in essence, is revealed to us through our interactions.
What we value is revealed to us through our relationships with
others. What gifts we have, what talents and abilities we
possess, only become real when they are enacted in community. The v dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ery meaning of our lives only becomes apparent to us in our
service to others. Given this, our next questions are directed outwardly. They pertain to the ways we manifest the gifts we discovered in our self-inquiry. They are questions that help us determine what to make of our tal cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin nts. As an individual, how can I do what I love while being of use to others? As an organizational leader, how can I create a forum that calls forth the ingenuity of individuals and assists them in applying that toward communal solutions? As a business leader, how can I deliver pr tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ofits to the shareholders while
rewarding fairly all those who made those profits possible? As
an educator, how can I make learning relevant and engage the
students in real-life problem-solving? In a radio interview the other day, the host asked me, "How do you help people know wh t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel t they want?" (I once thought that was a
silly question, but have since realized that most of us need
help clarifying our deepest desires). Since our education was more a matter of *what to think* than *how to think*, many of us never learned the process of inner inquiry. By defa ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ult, we end up being perfect consumers, going into debt
for what advertisers tell us we need and want when what we'd
really like is to work less and have a little cabin on a
mountain lake—which would be absolutely do-able if we weren’t
paying for all those other things we really di y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products n't want. So a crucial part of original thinking is the clear-cutting of all thoughts that are not our own, and the answering of our own deep questions. If you aspire to lead, then you will need to do this for yourself first, then find ways to help others engage in the same proce . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ss. The more self-awareness each individual has, the
greater the potential of the group to succeed. When everyone comes to the table from a place of total freedom, with an unadulterated willingness to serve, with full access to their feelings and inner resources, and an awareness o elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip the
group’s mission and power to fulfill it, then that circle of
individuals will be capable of achieving whatever they can
imagine. Excerpted and adapted from the forthcoming book The Art of Original Thinking: The Making of a Thought Leader, 9th Element Press © 2006 Jan Phillip tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Kill 'Em With Kindness - Managing With A Positive Attitude
|